Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.

Authors:
Ing Shian Soon
Ing Shian Soon
University of Calgary
Canada
Kevin Fonseca
Kevin Fonseca
University of Calgary
Calgary | Canada
Sharon Feng
Sharon Feng
University of Alberta
Caitlin Goedhart
Caitlin Goedhart
University of Calgary
Calgary | Canada
Susan Kuhn
Susan Kuhn
University of Calgary
Calgary | Canada
Otto G Vanderkooi
Otto G Vanderkooi
University of Calgary
Calgary | Canada

Inflamm Bowel Dis 2018 Dec 14. Epub 2018 Dec 14.

Section of Paediatric Gastroenterology, Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada.

Background: Data on the serologic status of childhood vaccines, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), are limited in inflammatory bowel disease (IBD). Therefore, we evaluated vaccine coverage and seroprotection, along with CMV and EBV seropositivity, in pediatric IBD.

Methods: In a cross-sectional study, demographic data, IBD history, vaccine records, and serum for antibodies against measles, mumps, rubella, diphtheria, tetanus, varicella, hepatitis B (HBV), CMV, and EBV were collected from children with IBD. We evaluated potential factors associated with serologic status.

Results: Of 156 subjects, vaccine coverage was up to date for age in 93.5% for measles, mumps, rubella, 95.6% for diphtheria, tetanus, pertussis, polio, hemophilus influenza B, 75.8% for HBV, and 93.5% for varicella, including past infection and vaccination. Seroprotection was present in 65.8% for measles, 60.5% for mumps, 79.1% for rubella, 79.5% for diphtheria, 80.8% for tetanus, 70.5% for varicella, and 62.8% for HBV of subjects. Older age at diagnosis was associated with seroprotection among subjects with complete HBV (odds ratio [OR], 1.20; 95% confidence interval [CI], 1.03-1.39) and rubella series (OR, 1.18; 95% CI, 1.02-1.37). Older age at serum collection was associated with seroprotection among subjects with prior varicella vaccination or infection (OR, 1.69; 95% CI, 1.33-2.15). Only 25.2% and 37.8% demonstrated seropositivity to CMV and EBV, respectively. Among subjects on immunosuppressive medications, 75.3% and 62.4% were seronegative for CMV and EBV, respectively.

Conclusions: Children with IBD have low serologic protection to childhood vaccines in spite of high vaccine coverage and universal vaccinations. Children with IBD, including a large proportion on immunosuppressive medications, have low seropositivity to CMV and EBV.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy366DOI Listing
December 2018
11 Reads

Publication Analysis

Top Keywords

cmv ebv
20
vaccine coverage
12
children ibd
12
childhood vaccines
12
diphtheria tetanus
8
seropositivity cmv
8
bowel disease
8
ibd evaluated
8
mumps rubella
8
seroprotection subjects
8
associated seroprotection
8
older age
8
measles mumps
8
inflammatory bowel
8
immunosuppressive medications
8
vaccines cytomegalovirus
8
serologic status
8
epstein-barr virus
8
ebv
6
cmv
6

References

(Supplied by CrossRef)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Ng et al.
Lancet. 2018
Intercenter variation in initial management of children with Crohn’s disease
Kappelman et al.
Inflamm Bowel Dis. 2007
Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007)
Benchimol et al.
Inflamm Bowel Dis. 2011
Disseminated primary varicella after initiation of infliximab for Crohn’s disease
Leung et al.
Am J Gastroenterol. 2004
Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis
Esteve et al.
Gut. 2004
Guidelines for immunizations in patients with inflammatory bowel disease
Sands et al.
Inflamm Bowel Dis. 2004
Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
Melmed et al.
Inflamm Bowel Dis. 2009
Vaccination strategies in pediatric inflammatory bowel disease
Dipasquale et al.
Vaccine. 2017
Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases
Benchimol et al.
Am J Gastroenterol. 2017
Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review
de-Thé et al.
IARC Sci Publ. 1975
Seroprevalence of cytomegalovirus infection in the United States, 1988-1994
Staras et al.
Clin Infect Dis. 2006

Similar Publications